Depreciation of Repare Therapeutics Inc. from 31 Dec 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Repare Therapeutics Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2019 to 31 Mar 2025.
  • Repare Therapeutics Inc. Depreciation for the quarter ending 31 Mar 2025 was $1,186,000, a 137% increase year-over-year.
  • Repare Therapeutics Inc. annual Depreciation for 2024 was $1,921,000, a 1.5% decline from 2023.
  • Repare Therapeutics Inc. annual Depreciation for 2023 was $1,951,000, a 1.4% decline from 2022.
  • Repare Therapeutics Inc. annual Depreciation for 2022 was $1,978,000, a 34% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Repare Therapeutics Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,186,000 +$685,000 +137% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $501,000 +$60,000 +14% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $441,000 -$75,000 -15% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $516,000 +$194,000 +60% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $322,000 +$126,000 +64% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $196,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1

Repare Therapeutics Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,921,000 -$30,000 -1.5% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 $1,951,000 -$27,000 -1.4% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $1,978,000 +$507,000 +34% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2024 2023 FY
2021 $1,471,000 +$574,000 +64% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2023 2022 FY
2020 $897,000 +$292,000 +48% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $605,000 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.